Off-label prescribing - Legal implications

被引：40

作者：

Henry, V ^{[1
]}

机构：

[1] St Johns Univ, Coll Pharm, Jamaica, NY 11439 USA

来源：

关键词：

D O I：

10.1080/01947649909511094

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

[No abstract available]

引用

页码：365 / 383

页数：19

共 40 条

[1]

[Anonymous], 1996, MMWR Recomm Rep, V45, P1

[2]

BOULDING, 1995, J PHARM L, V4, P136

[3]

BROSGART, 1996, PED, V98, P143

[4] Off-label drug use in human immunodeficiency virus disease [J].

Brosgart, CL ;

Mitchell, T ;

Charlebois, E ;

Coleman, R ;

Mehalko, S ;

Young, J ;

Abrams, DI .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (01) :56-62

[5]

CARDWELL, 1997, J LEGAL MED, V18, P511

[6]

CHRISTOPHER WL, 1993, FOOD DRUG LAW J, V48, P247

[7]

COHEN, 1997, STAR LEDGER 1012

[8]

CONLAN, 1997, HOPS PHARM REP OCT, P66

[9]

CONLAN, 1996, DRUG TOPICS 1021, P60

[10]

COTE, 1997, PEDS ANAESTH, V7, P91